Information for investors

News Release

Cambrex to Announce First Quarter 2018 Financial Results on May 3, 2018

EAST RUTHERFORD, N.J., April 26, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that first quarter 2018 financial results will be released on Thursday, May 3, 2018 before the market opens.

The Company will host a conference call to discuss the financial results.

   
  First Quarter 2018 Earnings Conference Call
   
     When: Thursday, May 3, 2018 at 8:30 a.m. Eastern Time
   
     Dial-in: 1-877-260-1479 for U.S.
  1-334-323-0522 for International
  Passcode:  5093025
   
     Dial-in Replay:          1-888-203-1112 for U.S.
  1-719-457-0820 for International
  Passcode:  5093025
  Available through Thursday, May 10, 2018
   
     Webcast: www.cambrex.com

About Cambrex

Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics.  The company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and continuous processing.  For more information, please visit www.cambrex.com.

Contact:            Stephanie LaFiura
  Investor Relations Associate
  Tel: 201-804-3037
  Email: stephanie.lafiura@cambrex.com

Primary Logo

Source: Cambrex Corporation